http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114213534-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-368 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22 |
| filingDate | 2022-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114213534-B |
| titleOfInvention | Anti-human PlGF mouse monoclonal antibody and its application |
| abstract | The invention discloses an anti-human PlGF mouse-derived monoclonal antibody, the monoclonal antibody is P1-Ab1, the amino acid sequence of the variable region of the heavy chain is shown in SEQ ID NO.1, and the amino acid sequence of the variable region of the light chain is shown in SEQ ID NO. 2; or, the monoclonal antibody is P1-Ab2, and its heavy chain variable region amino acid sequence is as shown in SEQ ID NO.3, and its light chain variable region amino acid sequence is as shown in SEQ ID NO.4, and this antibody pair PlGF protein has strong affinity and specificity. In addition, the present invention also discloses a chemiluminescence kit prepared by using the antibody, which has high sensitivity and precision and can meet application requirements. It can fill the corresponding raw material demand, promote the improvement of the corresponding detection, be beneficial to the prevention and treatment of preeclampsia, and improve the quality of fertility. |
| priorityDate | 2022-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 278.